Alerts will be sent to your verified email
Verify EmailBALAXI
|
Balaxi Pharma.
|
Panchsheel Organics
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
28.02 % | 13.3 % | 0.0 |
|
5yr average Equity Multiplier
|
1.4 | 1.38 | 1.68 |
|
5yr Average Asset Turnover Ratio
|
1.43 | 0.78 | 0.62 |
|
5yr Avg Net Profit Margin
|
11.03 % | 12.43 % | -21.45 % |
|
Price to Book
|
0.62 | 1.15 | 1.22 |
|
P/E
|
15.71 | 12.96 | 6.51 |
|
5yr Avg Cash Conversion Cycle
|
154.28 Days | 170.03 Days | 23.75 Days |
|
Inventory Days
|
87.41 Days | 123.02 Days | 83.11 Days |
|
Days Receivable
|
103.86 Days | 126.46 Days | 80.26 Days |
|
Days Payable
|
63.18 Days | 112.93 Days | 163.46 Days |
|
5yr Average Interest Coverage Ratio
|
57.05 | 43.42 | -11.18 |
|
5yr Avg ROCE
|
36.52 % | 17.97 % | -11.18 % |
|
5yr Avg Operating Profit Margin
|
16.64 % | 17.91 % | -10.26 % |
|
5 yr average Debt to Equity
|
0.09 | 0.07 | 0.18 |
|
5yr CAGR Net Profit
|
-5.76 % | 22.45 % | -12.45 % |
|
5yr Average Return on Assets
|
18.47 % | 9.61 % | -13.31 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.99 % | 56.12 % | 52.62 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.58 % | -1.96 % | -13.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 9.9 % |
|
Balaxi Pharma.
|
Panchsheel Organics
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|